Roivant Sciences Ltd.
Immunovant, Inc. · Director, 10% Owner
Roivant Sciences Ltd. is listed in filings as Director, 10% Owner at Immunovant, Inc.. This profile follows SEC Form 4 activity through Dec 12, 2025, including purchase activity. Recent filings connect the profile to Immunovant, Inc. (IMVT). The current snapshot covers public activity from Jan 15, 2025 to Dec 12, 2025. Reported amounts are shown as $350.0M to $336.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $350M16.7M shares | BuyDec 12, 2025 | $21.00 | $38.96 |